System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes

María Domercq1, María Victoria Sánchez-Gómez, Catherine Sherwin

  • 1Departamento de Neurociencias, Universidad del País Vasco, Leioa, Vizcaya, Spain.

Insights

Reactive microglia disrupt glutamate homeostasis, causing oligodendrocyte death in white matter disorders. Blocking alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors or system xc- prevents this injury.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Elevated extracellular glutamate leads to excitotoxic oligodendrocyte death, contributing to demyelination in white matter disorders like multiple sclerosis.
  • The precise mechanisms altering glutamate homeostasis in these conditions are not fully understood.

Purpose of the Study:

  • To investigate how microglial cells influence glutamate homeostasis and contribute to oligodendrocyte injury.
  • To elucidate the role of microglial activation in the pathogenesis of white matter disorders.

Main Methods:

  • Utilized cultured oligodendrocytes and mixed glial cultures exposed to activated microglial cells.
  • Employed whole-mount rat optic nerve models with lipopolysaccharide (LPS) exposure.
  • Assessed the impact of blocking alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate receptors and the cystine-glutamate antiporter system xc-.

Main Results:

  • Activated microglia compromise oligodendrocyte glutamate homeostasis by releasing glutamate via system xc- and blocking oligodendrocyte glutamate transporters.
  • This leads to increased extracellular glutamate and subsequent oligodendrocyte death, characterized by mitochondrial swelling.
  • Inhibition of AMPA/kainate receptors or system xc- prevented microglial-induced oligodendrocyte injury in vitro and in vivo.

Conclusions:

  • Reactive microglia play a significant role in altering glutamate homeostasis, contributing to oligodendrocyte death and white matter damage.
  • Targeting microglial activity, specifically system xc- and AMPA/kainate receptors, offers potential therapeutic strategies for white matter disorders.